Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 764532 |
Trade Name | |
Synonyms | BI-764532|BI764532|Obrixtamig |
Drug Descriptions |
BI 764532 is a bispecific antibody targeting DLL3 and CD3, which may lead to activation of T-cell-mediated immune response against DLL3-expressing tumor cells (J Clin Oncol 41, 2023 (suppl 16; abstr 8502)). |
DrugClasses | CD3 Antibody 99 DLL3 Antibody 6 |
CAS Registry Number | 2851943-09-2 |
NCIT ID | C177765 |